Literature DB >> 8764071

Recombinant human immunodeficiency virus type 1 genomes with tat unconstrained by overlapping reading frames reveal residues in Tat important for replication in tissue culture.

C Neuveut1, K T Jeang.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) Tat is essential for virus replication and is a potent trans activator of viral gene expression. Evidence suggests that Tat also influences virus infectivity and cytopathicity. Extensive structure-function studies of Tat in subgenomic settings with point mutagenesis and transient transfection readouts have been performed. These reporter assays have defined certain amino acid residues as being important for trans activation of reporter plasmids. However, they have not directly addressed functions related to virus replication. Here, we have studied Tat structure-function in the setting of replicating viruses. We characterized mutations that emerged in Tat during HIV-1 infections of T lymphocytes. To ensure that the selection pressure for change was directed toward protein function, we constructed HIV-Is in which the Tat reading frame was freed from constraints exerted by overlapping with the reading frames of vpr, rev, and env. When these recombinant viruses were passaged in T cells, 26 novel nucleotide changes in tat were observed from sequencing of 220 independently isolated clones. Recloning of these changes into a pNL4-3 molecular background allowed for the characterization of residues in Tat important for virus replication. Interestingly, many of the changes that affected replication when they were assayed in transient trans activation of plasmid reporters were found to be relatively neutral. We conclude that the structure-function of Tat in virus replication is incompletely reflected by activity measurements based only on subgenomic transient transfections.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8764071      PMCID: PMC190517     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  68 in total

1.  Natural HIV-1 NEF accelerates virus replication in primary human lymphocytes.

Authors:  A de Ronde; B Klaver; W Keulen; L Smit; J Goudsmit
Journal:  Virology       Date:  1992-05       Impact factor: 3.616

2.  Functional analysis of biologically distinct genetic variants of simian immunodeficiency virus isolated from a mandrill.

Authors:  H Sakai; J Sakuragi; S Sakuragi; R Shibata; A Adachi
Journal:  Virology       Date:  1992-07       Impact factor: 3.616

3.  Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection.

Authors:  F Kirchhoff; T C Greenough; D B Brettler; J L Sullivan; R C Desrosiers
Journal:  N Engl J Med       Date:  1995-01-26       Impact factor: 91.245

4.  Human immunodeficiency virus type 1 Vif- mutant particles from restrictive cells: role of Vif in correct particle assembly and infectivity.

Authors:  A M Borman; C Quillent; P Charneau; C Dauguet; F Clavel
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

5.  Single amino acid change in Tat determines the different rates of replication of two sequential HIV-1 isolates.

Authors:  M LeGuern; T Shioda; J A Levy; C Cheng-Mayer
Journal:  Virology       Date:  1993-08       Impact factor: 3.616

6.  Tat protein of human immunodeficiency virus type 1 represses expression of manganese superoxide dismutase in HeLa cells.

Authors:  S C Flores; J C Marecki; K P Harper; S K Bose; S K Nelson; J M McCord
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

7.  Host range, replicative, and cytopathic properties of human immunodeficiency virus type 1 are determined by very few amino acid changes in tat and gp120.

Authors:  C Cheng-Mayer; T Shioda; J A Levy
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

8.  Anti-HIV type 1 cytotoxic T lymphocyte effector activity and disease progression in the first 8 years of HIV type 1 infection of homosexual men.

Authors:  C R Rinaldo; L A Beltz; X L Huang; P Gupta; Z Fan; D J Torpey
Journal:  AIDS Res Hum Retroviruses       Date:  1995-04       Impact factor: 2.205

9.  Augmentation of virus secretion by the human immunodeficiency virus type 1 Vpu protein is cell type independent and occurs in cultured human primary macrophages and lymphocytes.

Authors:  U Schubert; K A Clouse; K Strebel
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

10.  The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages.

Authors:  M D Miller; M T Warmerdam; I Gaston; W C Greene; M B Feinberg
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

View more
  20 in total

1.  Role for human immunodeficiency virus type 1 Tat protein in suppression of viral reverse transcriptase activity during late stages of viral replication.

Authors:  M Kameoka; L Rong; M Götte; C Liang; R S Russell; M A Wainberg
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

2.  Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1.

Authors:  H Xiao; C Neuveut; H L Tiffany; M Benkirane; E A Rich; P M Murphy; K T Jeang
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

3.  Selection of TAR RNA-binding chameleon peptides by using a retroviral replication system.

Authors:  Baode Xie; Valerie Calabro; Mark A Wainberg; Alan D Frankel
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

4.  Jembrana disease virus Tat can regulate human immunodeficiency virus (HIV) long terminal repeat-directed gene expression and can substitute for HIV Tat in viral replication.

Authors:  H Chen; J He; S Fong; G Wilcox; C Wood
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

5.  Functional Segregation of Overlapping Genes in HIV.

Authors:  Jason D Fernandes; Tyler B Faust; Nicolas B Strauli; Cynthia Smith; David C Crosby; Robert L Nakamura; Ryan D Hernandez; Alan D Frankel
Journal:  Cell       Date:  2016-12-15       Impact factor: 41.582

6.  A second-site mutation that restores replication of a Tat-defective human immunodeficiency virus.

Authors:  K Verhoef; B Berkhout
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

7.  Broad antiretroviral activity and resistance profile of the novel human immunodeficiency virus integrase inhibitor elvitegravir (JTK-303/GS-9137).

Authors:  Kazuya Shimura; Eiichi Kodama; Yasuko Sakagami; Yuji Matsuzaki; Wataru Watanabe; Kazunobu Yamataka; Yasuo Watanabe; Yoshitsugu Ohata; Satoki Doi; Motohide Sato; Mitsuki Kano; Satoru Ikeda; Masao Matsuoka
Journal:  J Virol       Date:  2007-10-31       Impact factor: 5.103

8.  Levels of major selenoproteins in T cells decrease during HIV infection and low molecular mass selenium compounds increase.

Authors:  V N Gladyshev; T C Stadtman; D L Hatfield; K T Jeang
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-02       Impact factor: 11.205

9.  Replication of human immunodeficiency viruses engineered with heterologous Tat-transactivation response element interactions.

Authors:  Baode Xie; Mark A Wainberg; Alan D Frankel
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

10.  HIV-1 Tat C-terminus is cleaved by calpain 1: implication for Tat-mediated neurotoxicity.

Authors:  Giovanni Passiatore; Slava Rom; Davide Eletto; Francesca Peruzzi
Journal:  Biochim Biophys Acta       Date:  2008-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.